Belpointe Asset Management’s Marker Therapeutics MRKR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,100	Closed	-$781	–	2279
2023 Q1	$781	Buy	1,100 +100	+10%	+$71	﹤0.01%	3516
2022 Q4	$2.66K	Buy	+1,000	New	+$2.66K	﹤0.01%	3165